SNHG12 and neoplasm: Exosome-derived SNHG12 promotes angiogenesis via the PBRM1/MMP10 axis, driving tumor growth [114], while SNHG9 inhibits the Hippo pathway through phosphatidic acid-induced LATS1 liquid–liquid phase separation, enhancing invasiveness [115].